The report highlights Boston Scientific's commitment to advancing science for life, focusing on their 2022 performance across environmental, social and governance (ESG) areas. Key highlights include achieving 76% renewable electricity, receiving SBTi approval for their net-zero greenhouse gas emission reduction targets, and serving over 33 million patients worldwide. The company also expanded their commitment to diversity, equity and inclusion (DE&I) by investing in equitable career opportunities and advancing DE&I initiatives globally.
Issuing Company Boston Scientific Corporation
Report Type Integrated Report
Report Language EN
Report Filesize 10.37 MB
No. of Pages 82 pages
Reporting periodJanuary 1, 2022-December 31, 2022
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; TCFD
Materiality Assessmenttrue
